Lynkcell Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (NCT03644459) | Lynkcell Inc. | 2019-04-03 |
Track Lynkcell Inc. automatically
Every clearance here is in the API, with alerts when new ones post.